BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28223157)

  • 1. Dose-dependent cochlear and vestibular toxicity of trans-tympanic cisplatin in the rat.
    Callejo A; Durochat A; Bressieux S; Saleur A; Chabbert C; Domènech Juan I; Llorens J; Gaboyard-Niay S
    Neurotoxicology; 2017 May; 60():1-9. PubMed ID: 28223157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage.
    Sergi B; Ferraresi A; Troiani D; Paludetti G; Fetoni AR
    Hear Res; 2003 Aug; 182(1-2):56-64. PubMed ID: 12948602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vestibular and cochlear ototoxicity from transtympanic streptomycin administration.
    Wanamaker HH; Slepecky NB; Cefaratti LK; Ogata Y
    Am J Otol; 1999 Jul; 20(4):457-64. PubMed ID: 10431887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
    Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
    J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
    Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
    Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity.
    Ding D; Stracher A; Salvi RJ
    Hear Res; 2002 Feb; 164(1-2):115-26. PubMed ID: 11950531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinchilla models of selective cochlear hair cell loss.
    McFadden SL; Ding D; Jiang H; Woo JM; Salvi RJ
    Hear Res; 2002 Dec; 174(1-2):230-8. PubMed ID: 12433413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin ototoxicity blocks sensory regeneration in the avian inner ear.
    Slattery EL; Warchol ME
    J Neurosci; 2010 Mar; 30(9):3473-81. PubMed ID: 20203207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.
    Sheehan K; Sheth S; Mukherjea D; Rybak LP; Ramkumar V
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29608150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin ototoxicity in rat cochlear organotypic cultures.
    Ding D; He J; Allman BL; Yu D; Jiang H; Seigel GM; Salvi RJ
    Hear Res; 2011 Dec; 282(1-2):196-203. PubMed ID: 21854840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear structure and function after round window application of ototoxins.
    Bauer CA; Brozoski TJ
    Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin: evaluation of its ototoxic potential.
    Anniko M; Sobin A
    Am J Otolaryngol; 1986; 7(4):276-93. PubMed ID: 3752388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.
    Maruyama A; Kawashima Y; Fukunaga Y; Makabe A; Nishio A; Tsutsumi T
    Hear Res; 2024 Jun; 447():109013. PubMed ID: 38718672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of peroxiredoxin I in cisplatin-induced ototoxicity.
    Le Q; Tabuchi K; Warabi E; Hara A
    Auris Nasus Larynx; 2017 Apr; 44(2):205-212. PubMed ID: 27318370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allicin protects against cisplatin-induced vestibular dysfunction by inhibiting the apoptotic pathway.
    Wu X; Cai J; Li X; Li H; Li J; Bai X; Liu W; Han Y; Xu L; Zhang D; Wang H; Fan Z
    Eur J Pharmacol; 2017 Jun; 805():108-117. PubMed ID: 28259711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
    Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
    Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin tympanoclysis: effects on the labyrinthine sensory cells.
    Pender DJ
    Laryngoscope; 2003 Feb; 113(2):343-8. PubMed ID: 12567093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death.
    Ylikoski J; Xing-Qun L; Virkkala J; Pirvola U
    Hear Res; 2002 Jan; 163(1-2):71-81. PubMed ID: 11788201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.